share_log

Summit Healthcare Acquisition (SMIH) Vs. Its Rivals Critical Contrast

Summit Healthcare Acquisition (SMIH) Vs. Its Rivals Critical Contrast

峰会医疗收购 (SMIH) vs.其竞争对手的关键对比
Defense World ·  2022/12/15 01:12

Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 publicly-traded companies in the "Holding & other investment offices" industry, but how does it compare to its competitors? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

顶峰医疗收购(纳斯达克:SMIH-GET评级)是710家上市公司之一,但与竞争对手相比,它的表现如何?我们将根据收购的机构所有权、分析师建议、估值、盈利能力、收益、股息和风险,将Summit Healthcare收购与类似公司进行比较。

Volatility and Risk

波动性和风险

Summit Healthcare Acquisition has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's competitors have a beta of 0.05, indicating that their average stock price is 95% less volatile than the S&P 500.

Summit Healthcare收购的贝塔系数为0.01,表明其股价的波动性比标准普尔500指数低99%。相比之下,Summit Healthcare收购的竞争对手的贝塔系数为0.05,这表明它们的平均股价波动性比标准普尔500指数低95%。

Get
到达
Summit Healthcare Acquisition
Summit Healthcare收购
alerts:
警报:

Profitability

盈利能力

This table compares Summit Healthcare Acquisition and its competitors' net margins, return on equity and return on assets.

此表比较了Summit Healthcare收购及其竞争对手的净利润率、股本回报率和资产回报率。

Net Margins Return on Equity Return on Assets
Summit Healthcare Acquisition N/A 46.53% 8.78%
Summit Healthcare Acquisition Competitors 11.67% -68.35% 2.51%
净利润率 股本回报率 资产回报率
Summit Healthcare收购 不适用 46.53% 8.78%
Summit Healthcare收购竞争对手 11.67% -68.35% 2.51%

Insider & Institutional Ownership

内部人与机构所有权

64.3% of shares of all "Holding & other investment offices" companies are owned by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
所有“控股及其他投资办事处”公司64.3%的股份由机构投资者持有。所有“控股及其他投资办事处”公司17.6%的股份由公司内部人士持有。强大的机构持股表明,对冲基金、捐赠基金和大型基金管理公司相信,一家公司有望实现长期增长。

Valuation and Earnings

估值和收益

This table compares Summit Healthcare Acquisition and its competitors top-line revenue, earnings per share (EPS) and valuation.

此表比较了Summit Healthcare收购及其竞争对手的营收、每股收益(EPS)和估值。

Gross Revenue Net Income Price/Earnings Ratio
Summit Healthcare Acquisition N/A -$550,000.00 12.51
Summit Healthcare Acquisition Competitors $1.72 billion $88.36 million 25.06
总收入 净收入 市盈率
Summit Healthcare收购 不适用 -$550,000.00 12.51
Summit Healthcare收购竞争对手 17.2亿美元 8836万美元 25.06

Summit Healthcare Acquisition's competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summit Healthcare收购的竞争对手的收入和收益都高于Summit Healthcare收购。Summit Healthcare收购的市盈率低于竞争对手,这表明它目前比行业内的其他公司更负担得起。

Analyst Recommendations

分析师建议

This is a summary of current ratings for Summit Healthcare Acquisition and its competitors, as reported by MarketBeat.

据MarketBeat报道,这是Summit Healthcare Acquisition及其竞争对手目前的评级摘要。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Summit Healthcare Acquisition 0 0 0 0 N/A
Summit Healthcare Acquisition Competitors 113 592 886 18 2.50
销售评级 保持评级 购买评级 强劲的买入评级 评级分数
Summit Healthcare收购 0 0 0 0 不适用
Summit Healthcare收购竞争对手 113 592 886 18 2.50

As a group, "Holding & other investment offices" companies have a potential upside of 65.14%. Given Summit Healthcare Acquisition's competitors higher probable upside, analysts plainly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.

作为一个整体,“控股和其他投资办公室”公司有65.14%的潜在上行空间。考虑到Summit Healthcare收购的竞争对手更有可能上行,分析师显然认为Summit Healthcare收购的增长方面不如竞争对手有利。

Summary

摘要

Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.

Summit Healthcare收购的竞争对手在比较的10个因素中有8个击败了Summit Healthcare收购。

About Summit Healthcare Acquisition

关于Summit Healthcare收购

(Get Rating)

(获取评级)

Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

Summit Healthcare Acquisition Corp.没有重大业务。拟与一个或者多个企业或者实体进行合并、换股、资产收购、股份购买、重组或者类似的业务合并。该公司成立于2020年,总部设在香港中环。

Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

收到Summit Healthcare收购日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Summit Healthcare收购和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发